Form 8K Cingulate Inc For: 10 November
- Investing.com
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Cingulate Inc (CING)
Cingulate Inc stock price live, this page displays NASDAQ CING stock exchange data. View the CING premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Cingulate Inc real time stock price chart below.
What Is the Cingulate Inc Stock Price Today?
The Cingulate Inc stock price today is 4.560.
What Is the Stock Symbol for Cingulate Inc?
The stock ticker symbol for Cingulate Inc is CING.
Is CING the Same as $CING?
$CING is a common way to refer to the Cingulate Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Cingulate Inc Trade On?
Cingulate Inc is listed and trades on the NASDAQ stock exchange.
Is Cingulate Inc a Good Stock to Buy?
Determining whether Cingulate Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Cingulate Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CING quote. (ISIN: US17248W3034)
What Is the Cingulate Inc Stock Price Today?
The Cingulate Inc stock price today is 4.560.
What Is the Stock Symbol for Cingulate Inc?
The stock ticker symbol for Cingulate Inc is CING.
Is CING the Same as $CING?
$CING is a common way to refer to the Cingulate Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Cingulate Inc Trade On?
Cingulate Inc is listed and trades on the NASDAQ stock exchange.
Is Cingulate Inc a Good Stock to Buy?
Determining whether Cingulate Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Cingulate Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CING quote. (ISIN: US17248W3034)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.465
4.845
52 wk Range
3.160
11.890
Earnings results expected in 7 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.4654.845
52 wk Range
3.16011.890
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CING Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
21.200
Upside
+364.91%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings upwards for the upcoming period
Form 8K Cingulate Inc For: 13 August- Investing.com
- Form 8K Cingulate Inc For: 10 November
- Investing.com
- Form 8K Cingulate Inc For: 13 August
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell
Analyst Ratings
4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 21.200
(+364.91% Upside)
Earnings
Latest Release
Aug 13, 2026
EPS / Forecast
-0.45 / -0.63
Revenue / Forecast
-- / --
Compare CING to Peers and Sector
Metrics to compare | CING | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCINGPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.3x | −5.7x | −0.2x | |
PEG Ratio | −0.05 | −0.19 | 0.00 | |
Price / Book | 2.8x | 1.7x | 2.6x | |
Price / LTM Sales | - | 2.7x | 2.8x | |
Upside (Analyst Target) | 364.9% | 117.0% | 60.9% | |
Fair Value Upside | Unlock | 7.2% | 9.5% | Unlock |
Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company’s lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials for the treatment of ADHD in children, adolescents, and adults. It also develops CTx-2103 (buspirone), which is in a formulation stage for the treatment of anxiety. In addition, the company plans to initiate a clinical plan for CTx-1302 (dextroamphetamine) to treat ADHD. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Cingulate (CING) Stock Price Today?
The Cingulate stock price today is 4.560 USD.
What Stock Exchange Does Cingulate Trade On?
Cingulate is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Cingulate?
The stock symbol for Cingulate is "CING."
What Is the Cingulate Market Cap?
As of today, Cingulate market cap is 66.310M USD.
What Is Cingulate's Earnings Per Share (TTM)?
The Cingulate EPS (TTM) is -3.28.
When Is the Next Cingulate Earnings Date?
Cingulate will release its next earnings report on Nov 18, 2026.
From a Technical Analysis Perspective, Is CING a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Cingulate Stock Split?
Cingulate has split 2 times.
How Many Employees Does Cingulate Have?
Cingulate has 14 employees.
What is the current trading status of Cingulate (CING)?
As of Nov 11, 2026, Cingulate (CING) is trading at a price of 4.560 USD, with a previous close of 4.560 USD. The stock has fluctuated within a day range of 4.465 USD to 4.845 USD, while its 52-week range spans from 3.160 USD to 11.890 USD.
What Is Cingulate (CING) Price Target According to Analysts?
The average 12-month price target for Cingulate is 21.200 USD, with a high estimate of 44 USD and a low estimate of 8 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +364.91% Upside potential.
What Is the CING Premarket Price?
CING's last pre-market stock price is 4.700 USD. The pre-market share volume is 3,120.000, and the stock has decreased by 0.250, or 5.620%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.